[
  {
    "ts": "2025-08-31T04:10:41+00:00",
    "headline": "Jefferies Reiterates a Buy Rating on CVS Health (CVS) With a PT of $80",
    "summary": "CVS Health Corporation (NYSE:CVS) is one of the top most undervalued low volatility stocks to buy now. In a report released on August 19, Brian Tanquilut from Jefferies reiterated a Buy rating on CVS Health Corporation (NYSE:CVS), setting a price target of $80.00. In a report released on August 18, UBS also upgraded the stock […]",
    "url": "https://finance.yahoo.com/news/jefferies-reiterates-buy-rating-cvs-041041584.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "2effad34-6179-3f79-bd78-fe388d4fabb9",
      "content": {
        "id": "2effad34-6179-3f79-bd78-fe388d4fabb9",
        "contentType": "STORY",
        "title": "Jefferies Reiterates a Buy Rating on CVS Health (CVS) With a PT of $80",
        "description": "",
        "summary": "CVS Health Corporation (NYSE:CVS) is one of the top most undervalued low volatility stocks to buy now. In a report released on August 19, Brian Tanquilut from Jefferies reiterated a Buy rating on CVS Health Corporation (NYSE:CVS), setting a price target of $80.00. In a report released on August 18, UBS also upgraded the stock […]",
        "pubDate": "2025-08-31T04:10:41Z",
        "displayTime": "2025-08-31T04:10:41Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4e33e0d1a07889115aefcb74e0ea299f",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "CVS Health’s (CVS) Dividend Outlook: Can the Retail-Pharma Giant Deliver in 2025?",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yrDm7iyVNAagx0oOilifnQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4e33e0d1a07889115aefcb74e0ea299f.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Q.L_4QVhEk8dUSgrDa_Iag--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4e33e0d1a07889115aefcb74e0ea299f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jefferies-reiterates-buy-rating-cvs-041041584.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jefferies-reiterates-buy-rating-cvs-041041584.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]